SHG:688266 - Suzhou Zelgen Biopharmaceuticals Co Ltd

Suzhou Zelgen Biopharmaceutica
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2016 Q4	2017 Q4	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-399.55M -	-	-454.62M -	-	-398.83M -	-	-370.34M -	-	-345.11M -	-	-232.75M -	-
Investing CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	446.06M -18.3%	287.24M -35.6%	326.66M 13.7%	47.65M -85.4%	20.88M -56.2%	-190.12M -	-264.06M -	-361.89M -	-705.97M -	-73.06M -	64.84M -	-176.57M -
Financing CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	161.04M 110.0%	131.66M -18.2%	93.99M -28.6%	138.61M 47.5%	80.75M -41.7%	197.2M 144.2%	282.79M 43.4%	311.52M 10.2%	1.57B 405.3%	1.57B -0.4%	1.51B -3.7%	1.5B -0.6%
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.13B 3.2%	1.16B 2.1%	1.12B -3.3%	1.35B 20.5%	1.34B -0.9%	1.13B -15.8%	1.08B -3.7%	1.12B 3.5%	1.04B -7.1%	730.86M -29.8%	736.11M 0.7%	733.96M -0.3%
Effect of FX Change	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-5.18M -	-2.42M -	-1.44M -	-2.11M -	2.26M -	5.63M 148.8%	4.07M -27.7%	4.13M 1.4%	1.39M -66.3%	-2.29M -	216.72K -	433.77K 100.2%
Changes in Cash	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	207.55M -18.1%	-30.06M -	-33.97M -	-225.15M -	-297.2M -	-399.81M -	-351.61M -	-391.84M -	523.12M -	1.18B 124.8%	1.34B 14.1%	1.21B -9.7%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.34B -0.8%	1.13B -16.0%	1.08B -3.9%	1.12B 3.7%	1.04B -7.5%	725.23M -30.2%	736.11M 1.5%	729.83M -0.9%	1.56B 114.4%	1.91B 21.9%	2.08B 9.0%	1.95B -6.4%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-464.88M -	-518.28M -	-525.36M -	-493.78M -	-490.01M -	-498.64M -	-458.97M -	-422.83M -	-418.8M -	-376.55M -	-295.35M -	-185.55M -